G01N 33/576
For hepatitis
Official title: for hepatitis
G01N33/576 (For hepatitis) appears on 463 US grants and 555 published applications in this corpus.
Search patents in G01N- Granted patents
- 463
- Published applications
- 555
- Assignees
- 386
- Inventors
- 1,398
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 1 | 0 |
| 1986 | 7 | 0 |
| 1987 | 10 | 0 |
| 1988 | 3 | 0 |
| 1989 | 9 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 9 | 0 |
| 1993 | 9 | 0 |
| 1994 | 12 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 22 | 0 |
| 1999 | 11 | 0 |
| 2000 | 16 | 0 |
| 2001 | 18 | 5 |
| 2002 | 12 | 27 |
| 2003 | 12 | 35 |
| 2004 | 12 | 30 |
| 2005 | 4 | 26 |
| 2006 | 13 | 32 |
| 2007 | 11 | 18 |
| 2008 | 16 | 32 |
| 2009 | 13 | 22 |
| 2010 | 21 | 44 |
| 2011 | 7 | 22 |
| 2012 | 7 | 17 |
| 2013 | 13 | 24 |
| 2014 | 13 | 23 |
| 2015 | 8 | 19 |
| 2016 | 11 | 20 |
| 2017 | 14 | 24 |
| 2018 | 13 | 21 |
| 2019 | 19 | 23 |
| 2020 | 8 | 20 |
| 2021 | 9 | 16 |
| 2022 | 14 | 18 |
| 2023 | 7 | 15 |
| 2024 | 3 | 7 |
| 2025 | 6 | 10 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and antibody for detection of HBcAg12 May 2026US 12,624,090 B2Xiamen Innodx Biotech Co., Ltd
- Methods of treating fulminant viral hepatitis with an IL-18 antagonist in a patient with an IL-18BP variant20 Jan 2026US 12,527,840 B2The Rockefeller University
- Exosome-mediated diagnosis of hepatitis virus infections and diseases6 Jan 2026US 12,517,129 B2Morehouse School of Medicine
- Kit of in vitro quantifying large surface protein of hepatitis B virus (HBV), biomarker set for analyzing phases of HBV infection and hepatoma prognosis, and set of monoclonal antibodies for predicting, diagnosing or treating chronic liver disease14 Oct 2025US 12,442,821 B2National Cheng Kung University
- Use of HLA-A*11:01-restricted hepatitis B virus (HBV) peptides for identifying HBV-specific CD8+ T cells16 Sep 2025US 12,414,990 B2Agency for Science, Technology and Research
- System and method for predicting or characterizing immune responses27 Aug 2026US 2026/0253746 A1Janssen Pharmaceutica NV
- Sensitizer for immunochromatographic measurements targeting hepatitis virus, specimen diluent for immunochromatographic measurements, immunochromatographic measurement method, tool for immunochromatographic measurements and test kit for hepatitis virus13 Aug 2026US 2026/0235611 A1Kawasaki Gakuen Educational Foundation
- Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (nash) and advanced liver fibrosis28 May 2026US 2026/0147000 A1Beth Israel Deaconess Medical Center, Inc.
- Hcv antigens and antibodies19 Mar 2026US 2026/0078172 A1The Johns Hopkins University
- Pharmaceutical composition that inhibits production of hepatitis b virus protein, pharmaceutical composition for treating hepatitis b, and screening method1 Jan 2026US 2026/0000699 A1FUJIFILM Corporation
Most cited
By later US patents
- Immunometric assays using monoclonal antibodies1,218US 4,376,110 AHybritech Incorporated · 1983
- Immunometric assays using monoclonal antibodies291US 4,486,530 AHybritech Incorporated · 1984
- Solid-phase analytical device and method for using same173US 4,916,056 AAbbott Laboratories · 1990
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Method and apparatus for heterogeneous chemiluminescence assay146US 5,089,424 AAbbott Laboratories · 1992